Aller au contenu

Interactions médicamenteuses

Blinatumomab + Siponimod

Gravité: Modérée

Blinatumomab and Siponimod: moderate interaction.

Dernière mise à jour

Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.

Le contenu clinique de cette page n'est disponible qu'en anglais.

Résumé

Blinatumomab engages T cells against CD19-positive B cells and causes B-cell depletion, cytopenias and infections. Combining it with siponimod, which reduces circulating lymphocytes, may add to infection risk and may blunt T-cell redirected activity.

Ce que signifie cette interaction, en termes simples

Blinatumomab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Blinatumomab belongs to Oncology; Siponimod belongs to Central Nervous System.

Niveau de preuve: Low

Pourquoi elle survient

Additive immune suppression from B-cell depletion and S1P-mediated lymphocyte sequestration.

Conduite à tenir

Monitor for infection and check blood counts regularly. Siponimod usually should be held during blinatumomab treatment, so decide this with the oncology and neurology teams.

Questions à poser à votre pharmacien

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Réservé aux membres Pro+

Débloquer la page complète

Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Blinatumomab et Siponimod, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.

Questions fréquentes

Can I take Blinatumomab with Siponimod?

MediHelp rates the interaction as moderate. Blinatumomab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Blinatumomab engages T cells against CD19-positive B cells and causes B-cell depletion, cytopenias and infections. Combining it with siponimod, which reduces circulating lymphocytes, may add to infection risk and may blunt T-cell redirected activity.

How serious is the interaction between Blinatumomab and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infection and check blood counts regularly. Siponimod usually should be held during blinatumomab treatment, so decide this with the oncology and neurology teams.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp

Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.

Parcourir de A à Z · Interactions médicamenteuses

Télécharger l'app Se connecter